Banking on consistent improvement in the company's Base business, Quest Diagnostics (DGX) raises its full-year 2022 guidance.
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.42% and 4.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics Inc. DGX, -1.33% said Thursday its second-quarter net income fell to $234 million, or $1.96 a share from $631 million, or $4.96 a share in the year-ago quarter. Adjusted profit in th

5 Dividend-Paying Stocks to Buy Ahead of Earnings Next Week

09:54am, Friday, 15'th Jul 2022 Zacks Investment Research
Five dividend-paying companies will report second-quarter 2022 earnings results next week. These are: HAL, FNB, DGX, SLB and NEP.
Five dividend-paying companies will report second-quarter 2022 earnings results next week. These are: HAL, FNB, DGX, SLB and NEP.
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quest Diagnostics (DGX) to Report Q2 Earnings: What's In Store?

04:00pm, Wednesday, 13'th Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) second-quarter 2022 results will likely have gained from an ongoing rebound in the base business.
Quest Diagnostics Inc. DGX, -1.38% said Wednesday that it developed a monkeypox test that it plans to launch in August. The PCR test, which is administered by a physician, can detect monkeypox and als

Quest Diagnostics (DGX), CDC Sign New COVID-19 Testing Deal

02:41pm, Monday, 11'th Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) and the CDC tie up to provide COVID testing for underserved communities free of cost across the United States.
Quest Diagnostics (DGX) and the CDC tie up to provide COVID testing for underserved communities free of cost across the United States.

Quest Diagnostics' (DGX) Base Business Grows Despite Margin Woes

02:33pm, Friday, 01'st Jul 2022 Zacks Investment Research
Quest Diagnostics (DGX) continues to make inroads with its health plans, gaining share and increasing revenues faster than the market.
Quest Diagnostics (DGX) continues to make inroads with its health plans, gaining share and increasing revenues faster than the market.

Walgreens Boots (WBA) Q3 Earnings Top Estimates, Revenues Miss

05:53pm, Thursday, 30'th Jun 2022 Zacks Investment Research
Walgreens Boots (WBA) reports better-than-expected Q3 earnings, with robust sales contributions from the International and Walgreens Health segments.

Option Care (OPCH) Stock Jumps 5.6%: Will It Continue to Soar?

10:02am, Monday, 27'th Jun 2022 Zacks Investment Research
Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE